• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Oriola

0.90 EUR

+1.35 %

7,767 following

ORIOLA

NASDAQ Helsinki

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+1.35 %
-1.43 %
-11.44 %
-21.91 %
-17.46 %
-13.82 %
-31.35 %
-51.93 %
-51.18 %

Oriola is a pharmaceutical group with a particular focus on the distribution of pharmaceuticals to other players in the industry. The company offers services to pharmacies and other pharmaceutical companies, which includes, for example, negotiations with suppliers and distribution of products. The largest operations are in the Nordic and Baltic regions. The headquarters are located in Espoo.

Read more
Market cap
166.42M EUR
Turnover
133.2K EUR
P/E (adj.) (26e)
EV/EBIT (adj.) (26e)
P/B (26e)
EV/S (26e)
Dividend yield-% (26e)
Coverage
Recommendation
Accumulate
Target price
Updated
17.06.2026
Disclaimer
Revenue and EBIT-%
EPS and dividend
Financial calendar
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
3rd party
ShowingAll content types

Forum discussions
A new extensive report on Oriola is out today. The company updated its financial targets and segment structure in the spring, and we have naturally updated our report and views accordingly. In the big picture, however, this remains a waiting phase in the sense that the IT system ...
6/17/2026, 6:34 AM
by Rauli_Juva
12
There have been changes in the ownership of the Swedish pharmacy company half-owned by Oriola. The Lithuanian owner of the other half has sold its stake in the Swedish pharmacy company from the Euroapotheca Group, which operated pharmacy activities, to another group company. Euroapotheca...
5/9/2026, 8:19 AM
by Aktivisti26
11
Quite valid points, largely the same issues I have raised regarding this myself. Coincidentally, I was just reviewing Oriola, so let’s include one image here that shows in a rather stark way how Kronans Apotek’s profitability has melted away, even though the 2022 merger should have...
5/22/2026, 7:26 AM
by Rauli_Juva
7
Another comment on Jussi Halme’s video regarding Oriola’s investments: A significant portion of this year’s Q1 sum of EUR 7.7 million went towards the land area for the Järvenpää logistics center. The “lead time” (paistoaika) for this is long, and thus it also burdens the result ...
6/4/2026, 6:43 AM
by kontrolleri
6
Rauli interviewed Oriola’s CFO Mats Danielsson Topics: 00:00 Introduction 00:13 Mats Danielsson 01:28 Key points of the updated strategy 05:48 Changes in strategy 06:38 Financial targets 07:41 Growth target 09:19 Profitability target 13:44 Investments 15:01 Associated company Kronans...
5/18/2026, 8:40 PM
by Sijoittaja-alokas
6
Let’s share this Jussi Halme video about Oriola here; the man usually talks a lot of sense. I haven’t had the chance to listen to it myself yet, but maybe it resonates with someone’s thoughts: https://www.youtube.com/watch?v=3orteSq7eXE
5/22/2026, 5:59 AM
by NukkeNukuttaja
5
Here are Rauli’s pre-event comments regarding Oriola’s CMD festivities to be held on May 12th Oriola already announced its new financial targets in connection with the Q1 results, which will be further presented at the Capital Markets Day on May 12th. We would particularly seek clarity...
5/11/2026, 5:11 AM
by Sijoittaja-alokas
4
Read more on our forum
Rauli Juva
Rauli Juva

Analyst

Latest research

Latest analysis report

Released: 23.06.2026

Latest extensive report

Released: 23.06.2026

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
17.7.
2026

Interim report Q2'26

29.10.
2026

Interim report Q3'26

Oriola, Webcast, Q2'26
Webcast7/17/2026, 7:00 AM

Oriola, Webcast, Q2'26

Oriola
Oriola Extensive Report: Patience prescribed
Extensive research8 hours ago by
Rauli Juva

Oriola Extensive Report: Patience prescribed

Oriola's stock looks cheap, but there are clear risks associated with both the balance sheet and operational activities.

Oriola
Regulatory press release6/12/2026, 2:00 PM

Oriola Oyj: Oriola's share buyback programme has been completed

Oriola

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release6/10/2026, 4:00 PM

Oriola Oyj: Acquisition of own shares during week 24, 2026

Oriola
Regulatory press release6/10/2026, 12:30 PM

Oriola Oyj: Composition of Oriola Corporation's Shareholders' Nomination Board

Oriola
Regulatory press release6/5/2026, 4:00 PM

Oriola Oyj: Acquisition of own shares during week 23, 2026

Oriola
Regulatory press release6/5/2026, 10:00 AM

CORRECTION: Oriola Corporation's Annual Report 2025 published

Oriola
Regulatory press release5/29/2026, 4:00 PM

Oriola Oyj: Acquisition of own shares during week 22, 2026

Oriola
Regulatory press release5/22/2026, 4:00 PM

Oriola Oyj: Acquisition of own shares during week 21, 2026

Oriola
Regulatory press release5/15/2026, 4:00 PM

Oriola Oyj: Acquisition of own shares during week 20, 2026

Oriola
Third party research5/13/2026, 6:43 AM

Oriola: Solid mid-term potential - Evli

With the financial targets announced earlier along with major investments known, Oriola’s CMD was limited in terms of significant new news, which we see as a positive given earlier concerns. More clarity was however provided on the roadmap to achieving...

Oriola
Press release5/11/2026, 10:00 AM

Oriola Oyj: Oriola focuses on profitable growth and value creation at Capital Markets Day

Oriola
Regulatory press release5/8/2026, 4:00 PM

Oriola Oyj: Acquisition of own shares during week 19, 2026

Oriola
Regulatory press release4/30/2026, 9:15 AM

Oriola Oyj: Oriola Corporation - Managers' transactions - Pajamo

Oriola
Regulatory press release4/30/2026, 9:15 AM

Oriola Oyj: Oriola Corporation - Managers' transactions - Axdorff

Oriola
Regulatory press release4/30/2026, 9:15 AM

Oriola Oyj: Oriola Corporation - Managers' transactions - Westerlund

Oriola
Regulatory press release4/30/2026, 9:15 AM

Oriola Oyj: Oriola Corporation - Managers' transactions - Carlsson Meyer

Oriola
Regulatory press release4/30/2026, 9:15 AM

Oriola Oyj: Oriola Corporation - Managers' transactions - Närhinen

Oriola
Regulatory press release4/30/2026, 9:15 AM

Oriola Oyj: Oriola Corporation - Managers' transactions - Nilsson

Oriola
Regulatory press release4/30/2026, 9:15 AM

Oriola Oyj: Oriola Corporation - Managers' transactions - Pärssinen

Oriola